Qiming Venture Partners For Profit

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Industry: Longevity Biomarkers
Investor Type: Fund Of Funds
Headquarters: Shanghai, Shanghai, China
Investment Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity
Employee Number: 51-100
Number Of Exists: 68
Estimated Revenue: US$9.5 billion
Founded Date: 2006-01-01